baber/WOPTO huggingface dataset:
Patent CS-234017-B2 (CS)
Inventor: DEDIC JOSEF
IPC: F03H99/00
Filed: 1980-05-29
Abstract: Vynález řeší zjednodušení konstrukce,
zvýšení účinnosti, spolehlivosti i zlepšení
letových vlastností pohonnou jednotkou,
která na základě využití vlnového
odporu prostředí vytváří strmé tlakové vlny
prudkým cyklickým odmrštovéním rázového členu
od základního tělesa, ke kterému je na
konci každého cyklu opět volně navracen
vratným členem.
Patent CS-203131-B2 (CS)
Title: Method of cleaning the nystatine
Inventor: METZGER JULIO
IPC: C12P19/62
Filed: 1976-10-15
Abstract: Crude, partially purified, or contaminated nystatin is purified by suspending the nystatin starting material in a lower alkanol, treating the suspension with an organic acid, filtering the suspension to remove residual solids, adding a chlorinated hydrocarbon solvent to the alkanol filtrate, neutralizing the mixture, and precipitating the nystatin by the addition of water.
Patent CS-212729-B2 (CS)
Title: Method of determining glycerol ester and fatty acid contents in aqueous media,and an enzymatic agent for carrying out the method
Inventor: BUCOLO GIOVANNI
IPC: G01N33/04
Filed: 1971-12-16
Abstract: 1373106 Determination of triglyceride CALBIOCHEM 30 Nov 1971 [16 Dec 1970] 55609/71 Heading G1B A glycerol ester of a fatty acid in an aqueous liquid, for example serum or milk is assayed by hydrolyzing the ester by adding a lipase and a protease to the liquid, then determining the amount of glycerol present in the resulting solution. The lipase may be from Chromobacterium viscosum or Rhizopus delemar; the protease may be chymotrypsin (exemplified), trypsin, a streptomyces griseus protease, elastase, papain or bromelin. The assay may be carried out (a) using a reagent comprising the lipase and protease, glycerol kinase, ATP, phosphoenol pyruvate (PEP), a magnesium ion source, pyruvate kinase (PK), lactate dehydrogenase (LDH) and NADH and measuring the decrease in optical density resulting from the oxidation of the NADH; (b) using the reagent as in (a), without the NADH and LDH, and reacting the pyruvate ion formed with dinitrophenyl hydrazine; (c) using the reagent as in (a), without the PEP, PK NADH and LDH, adding glycerol phosphate dehydrogenase and NAD, and measuring increase in fluorescence produced by formation of NADH, or optionally also including in the reaction mixture dinitrophenyl hydrazine which forms a coloured product with dihydroxyacetone phosphate; or (d) using a reaction mixture which comprises the lipase, protease, NAD and glycerol dehydrogenase and measuring the increase in optical density, resulting from formation of NADH, or alternatively adding dinitrophenylhydrazine to form a coloured product  with the dihydroxyacetone in the reaction mixture. In other methods the NADH formed may be determined by reaction with a tetrazolium salt in the presence of a hydrogen transfer agent  such as diaphorase or phenazine methosulphate to form a coloured dye.
Patent CS-243465-B2 (CS)
Title: Cultural plants protection agent method of efficient component production
Inventor: BURDESKA KURT
IPC: C07D239/30
Filed: 1981-12-22
Abstract: Phenylpyrimidines of the formula I as defined below are suitable as antidotes for protecting cultivated plants from phytotoxic effects caused by herbicides. These antidotes, either together with the herbicides or also by themselves, are applied to the plants or incorporated in the soil in which the plants grow, or they are used to treat the seeds of the plants. Suitable herbicides are those belonging to the class of the haloacetanilides, haloacetamides, thiocarbamates, carbamates, nitroanilides, triazines, phenylureas, haloacetic acids, phenoxy- and pyridyloxyphenoxyalkanecarboxylic acid derivatives, benzoic acid derivatives etc. The phenylpyrimidines have the formula I    <IMAGE>  (I)  wherein for example, R1 and R3 are halogen.
Patent JP-S5941480-B2 (JP)
IPC: C11D1/06
Filed: 1977-01-14
Abstract: A single liquid phase detergent composition, such as a foam bath product, contains an alkyl monoglyceride as a skin benefit agent, an anionic detergent and water. In use, when diluted in water, the composition is capable of producing and maintaining a substantial head of foam and is capable of depositing on the skin, after immersion, a noticeable amount of the alkyl monoglyceride.
Patent JP-3060318-B2 (JP)
IPC: C09D11/00
Filed: 1991-01-23
Granted: 2000-07-10
Abstract: An ink comprises a recording agent and a liquid medium capable of dissolving or dispersing the recording agent. The ink contains a compound represented by the following Formula (I).    R1-CONH-R2   (I)   wherein R1 represents an alkyl group or aryl group unsubstituted or substituted with a group selected from a hydroxyl group, a carboxyl group, a sulfone group, an amino group and an acetylamino group; and R2 represents a hydrogen atom, an amide group, an aminoalkyl group, an aliphatic carboxylic acid residual group, or an aryl group unsubstituted or substituted with a group selected from a hydroxyl group, a carboxyl group, a sulfone group, an amino group and an acetylamino group; provided that R1 represents the unsubstituted or substituted aryl group when R2 is a hydrogen atom. The ink is suitably used in the ink-jet recording. <IMAGE>
Patent AU-713952-B2 (AU)
Title: Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
Inventor: STEMMER WILLEM P C
IPC: C12N9/38
Filed: 1996-12-02
Granted: 1999-12-16
Abstract: A method of producing a recombined polynucleotide having a desired characteristic, comprising:(a) providing a population of single-stranded nucleic acid fragments corresponding to a set of related-sequence polynucleotides, wherein the set of related-sequence polynucleotides comprises polynucleotides with non-identical sequences;(b) providing at least one template polynucleotide wherein the population of single-stranded fragments is capable of hybridizing to the at least one template polynucleotide;(c) hybridizing the population of single-stranded fragments to the at least one template polynucleotide and extending the hybridized fragments on the at least one template polynucleotide with a polymerase, thereby forming a plurality of sequence-recombined polynucleotides, said sequence-recombined polynucleotides comprising sequences from the set of related-sequence polynucleotides and sequences derived from the at least one template polynucleotide; and,(d) selecting or screening the sequence-recombined polynucleotides for the desired characteristic.
Patent AU-587928-B2 (AU)
Title: Pipe joint pressure testing means
Inventor: SCHMITZ THOMAS R
IPC: F16L21/00
Filed: 1988-02-17
Granted: 1989-08-31
Abstract: An apparatus for joining two tubular members B and P together at a subsea location wherein one of the tubular members has internal grooves 90, 92, 94 and the second tubular member is sufficiently small to slide into the first tubular member and the first tubular member has an external flange suitable for connection to a flowline, which apparatus includes a tubular mandrel 10 having means for connecting to said first tubular member B, a resilient sleeve 60a surrounding said mandrel and adapted to be positioned within said second tubular member P, volume compensating means 98 positioned within each of said grooves and testing means 70 carried by said mandrel to allow testing of the joint while the mandrel is still in position after forming. A method of joining tubular members at a subsea location including the steps of inserting the second tubular member within the first tubular member after the volume compensators have been inserted in the internal grooves in the first member, exerting fluid pressure on the interior of the second tubular to form the second tubular member against the internal grooves of the first tubular member and testing the formed joint while the mandrel is still in position within said second tubular member.A second form of the invention includes the use of microspheres in an epoxy matrix positioned in internal grooves of the bell which are designed to collapse at pressures above the water pressure at the depth of the installation of the joint and at a pressure below the pressures which develop in trapped sea water in the groove during forming.
Patent AU-752732-B2 (AU)
Title: Oscillator and telecommunications system with such an oscillator
Inventor: RITTER RUDOLF
IPC: G06F1/04
Filed: 1998-12-01
Granted: 2002-09-26
Abstract: The oscillator integrated into a chip can generate an electrical clock signal with a reference signal, wherein the chip contains the following components: at least one laser transmitter, which can generate two coherent light signals with a differing optical transmission frequency, a coupler, in order to merge the two light signals, an electromagnetic converter, which can generate an electrical signal, whose frequency corresponds to the distance between the two transmission frequencies, a frequency divider, which can divide the frequency of the electrical signal in order to deliver a clock signal with a lower frequency. The oscillator can be inserted into a SIM card, for example, in order to make possible a non-falsifiable determination of the connection duration.
Patent AU-563870-B2 (AU)
Title: Fluid injection system
Inventor: VINOKUR MICHAEL
IPC: F02B/
Filed: 1983-03-23
Granted: 1987-07-23
Abstract: A novel pump suitable for use in a water injection system of an internal combustion engine is described. The pump controls the rate of flow of water injected into the engine. The pump includes a variable pressure inducing means for pressurizing the water contained in the pump. The variable pressure inducing means is responsive to negative back pressure developed in the intake manifold of the engine and varies the pressure of the water in accordance with changes in the negative back pressure of the manifold. As the negative back pressure decreases, the pressure of the water increases which in turn increases the flow rate of fluid from the pump into the engine. There is also disclosed a pressure sensitive nozzle for controlling the flow of fluid exiting from the nozzle as a function of fluid pressure. The nozzle includes an auxiliary fluid flow path through the nozzle that has an inlet opening of variable size. The nozzle further includes a pressure sensitive piston that provides a primary fluid flow path through the nozzle. The pressure sensitive piston normally blocks the inlet of the auxiliary flow path. In response to a pressure build up above the predetermined value in the primary fluid flow path of the piston, the piston moves thereby increasing the size of the inlet of the auxiliary flow path as the pressure build up in the primary flow path increases above the predetermined value.
Patent AU-638893-B2 (AU)
Title: Veress needle assembly
IPC: A61B19/00
Filed: 1992-04-28
Granted: 1993-07-08
Abstract: A Veress needle instrument consists of a housing (1) serving as a handle, a hollow needle (21) having one end mounted in the housing and a pointed other end, a tube slidably mounted within the needle, the tube having one end sealed off and a side wall hole (31) proximate the sealed end, the other end of the tube passing through the hollow needle and into the length of a passageway of a spring (121) biased bobbin (29) mounted in the housing, with the other end being secured in the passageway. The passageway of the bobbin opens into a porthole thereof for receiving a fluid coupling through a hole in the top end of the housing, thereby permitting fluid to be passed directly between the tube and the fluid coupling. The bobbin is normally biased toward the bottom end of the housing, for causing the one end of the tube to extend away from a pointed end of the needle with the side hole of the tube unobstructed. When a force directed against the end of the tube causes it to retract into the needle, the bobbin moves toward the top end of the housing, causing a colored portion of the bobbin to protrude out of the hole in the top end of the housing, for providing a visual indication that the one end of the tube has retracted into the needle. <IMAGE>
Patent AU-569251-B2 (AU)
Title: Improved fiber optic sensor for detecting very small displacements of a surface
Inventor: KINO GORDON S
IPC: G01H9/00
Filed: 1983-04-13
Granted: 1988-01-28
Abstract: A light source (10) coupled to a first fiber optic waveguide (14) which is coupled by a first directional coupler (22) and a second directional coupler (24) to a second waveguide (20). The first waveguide (14) has a phase modulator (60), a delay loop (62) and a polarization controller (68) therein to cause a differential delay time T on counterpropagating coherent light waves phase modulated at a frequency 1M. The first directional couplier (22) has one part connected to a photodector (28) and the second directional coupler (24) has a probe (20D) coupled to the first fiber (14) and the second fiber (20). The probe directs light toward a surface (18) whereupon the counterpropagating waves are shifted in phase by an amount proportional to the amplitude of displacement of the surface 18.
Patent AU-610178-B2 (AU)
Title: Cough/cold mixtures comprising non-sedating antihistamine drugs
Inventor: SIEGEL CAROLE E
IPC: A61K31/455
Filed: 1988-04-22
Granted: 1991-05-16
Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with a non-sedating antihistamine and optionally one or more other active components selected from a decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold, cold-like and/or flu symptoms and the discomfort, pain, headache, fever and general malaise associated therewith.
Patent AU-566225-B2 (AU)
Title: Substituted phenothiazine derivatives
Inventor: DAVIDSON ARNOLD B
IPC: C07D279/28
Filed: 1983-07-28
Granted: 1987-10-15
Abstract: Substituted (10H-phenothiazin-10-yl)propyl-1-piperazines of the formula    <IMAGE>  I  wherein R1, R2, R3, A, X, m, n and s are as hereinafter set forth, are described. The compounds of formula I, which contain a piperazine moiety combined by an ether linkage to different phenolic moieties, are useful as orally active long lasting antipsychotic agents.
Patent AU-651699-B2 (AU)
Title: Method and articles for performing solid phase immunoassays
Inventor: SINOR LYLE T
IPC: G01N33/50
Filed: 1992-06-18
Granted: 1994-07-28
Abstract: A method for drying mammalian cells, such as erythrocytes, lumphocytes, leukocytes and platelets onto a solid-phase support for use in solid-phase immunoassays through use of a drying solution and an article for use in immunoassays prepared by such method. The method comprises immobilizing a monolayer of cells onto the solid-phase support by non-covalent binding. This is accomplished by staining the solid-phase support with an organic dye having a net positive charge which permits non-covalent binding of the cells which carry a net negative charge to the solid-phase support. These cells are dried or fixed to the solid-phase support by addition of a drying solution which comprises an aqueous solution of a monosaccharide, disaccharide, trisaccharide or cyclitol and a salt. The preferred monosaccharide is D-(-)glucose and the preferred salt is sodium chloride. The preferred drying solution comprises a 1.0M solution of dextrose and a 154mM solution of sodium chloride. The drying solution is contacted with the immobilized cells and immediately decanted and any excess water or drying solution is removed by drying the solid-phase support in a sealed pouch with a dessicant material for 3-8 days at between 2-8 DEG C. The preferred amount of time required for complete drying is 7 days at 2-8 DEG C.
Patent AU-668865-B2 (AU)
Title: Compositions for the prevention and/or treatment of pathological processes
Inventor: COHEN IRUN R
IPC: A61P3/08
Filed: 1992-05-01
Granted: 1996-05-23
Abstract: The present invention relates to methods for the prevention and/or treatment of pathological processes involving the induction of TNF- alpha  secretion comprising a pharmaceutically acceptable carrier and a low molecular weight heparin (LMWH). In the pharmaceutical compositions of the present invention, the LMWH is present in a low effective dose and is administered at intervals of about 5-8 days. Furthermore, the LMWH is capable of inhibiting in vitro TNF- alpha  secretion by resting T cells and/or macrophages in response to T cell-specific antigens, mitogens, macrophage activators, disrupted extracellular matrix (dECM), laminin, fibronectin, and the like.
Patent AU-753340-B2 (AU)
Title: A method and device for operating electronic ballasts for high intensity discharge (HID) lamps
Inventor: POGADAEV VLADIMIR
IPC: H05B41/24
Filed: 1999-01-20
Granted: 2002-10-17
Abstract: A method and device for operating electronic ballasts for high intensity discharge lamps, the ballasts having a driver, two power switches, an LC series circuit, a driver controller, a current sensor, and a power sensor. The method includes the steps of (a) generating pulses of frequency f1 for a time t1, equal to n/f1, where f1 equals the LC resonance frequency; (b) monitoring the existence of current and (c) monitoring the current in the lamp circuit, and proceeding to (h) upon determining that there is no current in the lamp circuit, (d) continuing pulse generation for a time t2; (e) switching the frequency f2, at which a set power is reached; (f) monitoring and stabilizing the lamp power by modifying f2, and proceeding to step (h) when the set power is exceeded; (g) monitoring current and power according to steps (c) and (f); h) inhibiting pulse generation for a time approximately equal to t2/k; (i) proceeding to step (a) until t2 has elapsed; and (j) inhibiting pulse generation until power is switched off and on.
Patent AU-660474-B2 (AU)
Title: Cookies containing psyllium
Inventor: PFLAUMER PHILLIP FLOYD
IPC: A21D2/36
Filed: 1992-07-22
Granted: 1995-06-29
Abstract: Disclosed are cookie containing psyllium and a method for making those cookies. The cookies may additionally contain polyol polyesters. These cookies provide an effective method for introducing psyllium into the diet to treat gastrointestinal disorders, such as constipation or diarrhea, as well as a method for introducing psyllium and polyol polyesters into the diet to reduce blood cholesterol levels.
Patent AU-602998-B2 (AU)
Title: Process for the preparation of meso 2,5-dihaloadipates
Inventor: O'NEILL BRIAN T
IPC: C07C51/62
Filed: 1988-08-05
Granted: 1990-11-01
Abstract: The present process produces the meso dialkyl 2,5-dihaloadipate from a mixture of the racemic dialkyl 2,5-dihaloadipate and meso 2,5-dihaloadipate. In the disclosed process, a 2,5-dihaloadipoyl halide is formed under conditions which result in the formation of an acidic compound. The 2,5-dihaloadipoyl halide is then esterified under conditions wherein the ester of the dihaloadipoyl halide is allowed to remain in contact with the acidic compound, thus allowing the racemic diester to epimerize in the presence of the acidic compound to the meso form and then the meso diester spontaneously crystallizes. In the last stage, the meso diester produced is removed.
Patent AU-768229-B2 (AU)
Title: Antiblock compositions and method of preparation
Inventor: DRUMMOND DONALD KENDALL
IPC: C08J5/18
Filed: 1999-12-22
Granted: 2003-12-04
Abstract: The present invention relates to a product, a process for its preparation and the use of such in plastic film production. More specifically, the present invention relates to an antiblock talc, a process for the preparation of such and its use as an additive in the production of polyolefin film. <??>Polyolefin films produced according to the process of the present invention are useful in a broad range of packaging and film covering applications.
Patent AU-627694-B2 (AU)
Title: Conjugates of cytokines with immunoglobulins
Inventor: WUSSOW PETER VON
IPC: A61K47/42
Filed: 1988-09-01
Granted: 1992-09-03
Abstract: The conjugates consist of a cytokine, for example interferon alpha, and human immunoglobulin, if required linked via an organic bridge and are used in pharmaceutical preparations for the treatment of viral infections and tumours. Compared with the free cytokine, the conjugates have a longer residence time in the plasma and tissue and thus improve the therapeutic effect.
Patent AU-668512-B2 (AU)
Title: Improved label printing apparatus
Inventor: CAYZER JOHN ANTHONY
IPC: B41J15/16
Filed: 1992-07-06
Granted: 1996-05-09
Abstract: PCT No. PCT/GB92/01223 Sec. 371 Date Mar. 3, 1994 Sec. 102(e) Date Mar. 3, 1994 PCT Filed Jul. 6, 1992 PCT Pub. No. WO93/01055 PCT Pub. Date Jan. 21, 1993The invention provides an improved label printing apparatus comprising, in a first aspect, a printer head for printing information on a plurality of labels carried on a backing sheet, the printer head being mounted on a carrier plate which is hingedly mounted along one edge thereof so as to be displaceable between a first printing position and a second non-printing position, the apparatus being provided with means to cause such displacement comprising first magnetic means arranged to hold the carrier plated in the second position against a force exerted by a spring which is compressed in this position, the means further including second magnetic means having a reversible polarity such that the carrier plated may be attracted or repelled thereto or repelled therefrom.
Patent AU-605364-B2 (AU)
Title: Modified tissue plasminogen activator
Inventor: BELL LESLIE DAVID
IPC: C12N15/12
Filed: 1988-10-07
Granted: 1991-01-10
Abstract: A modified t-PA having improved in vivo half-life is disclosed comprising in sequence a fibronectin finger-like domain F, a sequence of two K2 kringle regions and a serine protease region SP, wherein the first of said kringles is free of any glycosylation site and the second of said kringles has a single glycosylation site.
Patent AU-604980-B2 (AU)
Title: Communications protocol for distributed station network
Inventor: WELLS CHARLES
IPC: H04L12/413
Filed: 1988-10-07
Granted: 1991-01-03
Abstract: A communication protocol is provided to enable one of a number of transmitters using a common transmission line to independently gain exclusive use of the line. Before transmitting data, a transmitter first monitors the line to establish that it is idle. If it is, the transmitter then asserts the line for an interval unique to that given device. Thereafter the transmitter monitors the device momentarily to determine that no other transmitter is asserting the line and, if so, the transmitter may then gain exclusive control of the line.
Patent AU-667483-B2 (AU)
Title: W/O microemulsions
Inventor: CONSTANTINIDES PANAYIOTIS PERI
IPC: C09K23/44
Filed: 1992-07-24
Granted: 1996-03-28
Abstract: Pharmaceutically acceptable, stable, self-emulsifying (w/o) microemulsions comprising (i) a lipophilic phase comprising a long-chain fatty acid triglyceride and a low HLB surfactant, (ii) an aqueous-based hydrophilic phase containing a water-soluble therapeutic agent, and (iii) a high HLB surfactant have improved drug delivery characteristics.